Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could simple blood tests spot sepsis sooner?

NCT ID NCT07537179

Knowledge-focused Sponsor: Oguz Gundogdu Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study examined whether certain blood cell measurements—monocyte distribution and ratios of white blood cells—can help detect sepsis in intensive care patients. Researchers followed 120 adults in the ICU, comparing these new markers with standard infection tests. The goal was to see if these simple blood counts could aid in faster or more accurate sepsis diagnosis.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

120 people

The number who actually took part.

Started

Oct 2022

Finished

Jan 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population consists of three groups: Group I: Control group - patients over 18 years of age, classified as ASA I-II, with no infection, who applied to the anesthesia outpatient clinic and did not meet any exclusion criteria; Group II: patients who were admitted to the intensive care unit for reasons other than sepsis and subsequently developed sepsis; Group III: patients admitted to the intensive care unit with a primary diagnosis of sepsis.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients monitored in the intensive care unit for at least 24 hours * Age over 18 years * Diagnosis of sepsis or septic shock Exclusion Criteria: * Patients with hematological diseases * Patients who have undergone organ or bone marrow transplantation * Patients diagnosed with AIDS * Patients receiving immunosuppressive therapy for any reason * Patients with chronic renal failure * Patients with liver failure not related to sepsis * Patients admitted due to intoxication * Patients with intracranial pathologies (e.g., mass, hemorrhage) that may lead to morbidity due to volume loading

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute phase biomarkers are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

infectious disease with sepsis Sepsis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Acute phase biomarkers Intensive care (ICU) Sepsis

Contacts and locations

Locations

  • Sivas Cumhuriyet University

    Sivas, Sivas, 58140, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.